SM suppresses the growth of human non-small cell lung cancer (NSCLC) by influencing the phosphatidylinositol 3-kinase/Akt (PI3-K/Akt) signaling pathway in vitro and in vivo. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.